tradingkey.logo

Envoy Medical Inc

COCH
0.738USD
+0.012+1.71%
Horarios del mercado ETCotizaciones retrasadas 15 min
15.87MCap. mercado
PérdidaP/E TTM

Envoy Medical Inc

0.738
+0.012+1.71%

Más Datos de Envoy Medical Inc Compañía

Envoy Medical, Inc. is a hearing health company. The Company is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.

Información de Envoy Medical Inc

Símbolo de cotizaciónCOCH
Nombre de la empresaEnvoy Medical Inc
Fecha de salida a bolsaMar 02, 2021
Director ejecutivoMr. Brent T. Lucas
Número de empleados42
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 02
Dirección4875 White Bear Parkway
CiudadWHITE BEAR LAKE
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal55110
Teléfono16513618000
Sitio Webhttps://www.envoymedical.com/
Símbolo de cotizaciónCOCH
Fecha de salida a bolsaMar 02, 2021
Director ejecutivoMr. Brent T. Lucas

Ejecutivos de Envoy Medical Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Brent T. Lucas
Mr. Brent T. Lucas
Chief Executive Officer, Director
Chief Executive Officer, Director
216.49K
+3.35%
Mr. Charles R. Brynelsen
Mr. Charles R. Brynelsen
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
50.00K
--
Mr. Robert Potashnick
Mr. Robert Potashnick
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Ms. Susan J. Kantor
Ms. Susan J. Kantor
Independent Director
Independent Director
--
--
Ms. Janis Smith-Gomez
Ms. Janis Smith-Gomez
Independent Director
Independent Director
--
--
Mr. Michael Crowe
Mr. Michael Crowe
Independent Director
Independent Director
--
--
Ms. Mona Patel
Ms. Mona Patel
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Brent T. Lucas
Mr. Brent T. Lucas
Chief Executive Officer, Director
Chief Executive Officer, Director
216.49K
+3.35%
Mr. Charles R. Brynelsen
Mr. Charles R. Brynelsen
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
50.00K
--
Mr. Robert Potashnick
Mr. Robert Potashnick
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Ms. Susan J. Kantor
Ms. Susan J. Kantor
Independent Director
Independent Director
--
--
Ms. Janis Smith-Gomez
Ms. Janis Smith-Gomez
Independent Director
Independent Director
--
--
Mr. Michael Crowe
Mr. Michael Crowe
Independent Director
Independent Director
--
--

Desglose de ingresos

Sin datos
Sin datos
Por negocio
Por región
Sin datos

Estadísticas de accionistas

Actualizado: sáb., 16 de ago
Actualizado: sáb., 16 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
NorthRock Partners, LLC
35.88%
Taylor (Glen A)
35.88%
Atlas Merchant Capital LLC
1.94%
The Vanguard Group, Inc.
1.38%
Weiss Asset Management
1.28%
Otro
23.64%
Accionistas
Accionistas
Proporción
NorthRock Partners, LLC
35.88%
Taylor (Glen A)
35.88%
Atlas Merchant Capital LLC
1.94%
The Vanguard Group, Inc.
1.38%
Weiss Asset Management
1.28%
Otro
23.64%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
39.37%
Individual Investor
37.15%
Private Equity
1.94%
Hedge Fund
1.67%
Investment Advisor/Hedge Fund
1.40%
Otro
18.47%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
57
12.73M
44.52%
+8.56M
2025Q2
70
23.44M
108.95%
+6.87M
2025Q1
77
13.16M
66.71%
-3.62M
2024Q4
150
12.62M
59.27%
-33.88M
2024Q3
159
13.83M
66.11%
-35.76M
2024Q2
163
13.88M
70.79%
-37.22M
2024Q1
162
13.71M
69.92%
-38.36M
2023Q4
154
4.83M
24.67%
-35.19M
2023Q3
153
6.18M
31.55%
-33.86M
2023Q2
150
4.03M
92.35%
-36.92M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
NorthRock Partners, LLC
10.29M
46.98%
+10.29M
--
Jun 30, 2025
Taylor (Glen A)
10.29M
46.98%
--
--
Apr 10, 2025
Atlas Merchant Capital LLC
555.53K
2.54%
--
--
Jun 30, 2025
The Vanguard Group, Inc.
394.96K
1.8%
--
--
Jun 30, 2025
Weiss Asset Management
368.14K
1.68%
-19.82K
-5.11%
Jun 30, 2025
Lucas (Brent T)
209.46K
0.96%
+7.74K
+3.84%
May 30, 2025
Focus Partners Wealth, LLC
212.66K
0.97%
--
--
Jun 30, 2025
DSG Capital Advisors, LLC
163.64K
0.75%
--
--
Jun 30, 2025
Arcus Capital Partners, LLC
187.57K
0.86%
--
--
Jun 30, 2025
Meteora Capital LLC
108.51K
0.5%
--
--
Apr 10, 2025
Ver más

ETFs relacionados

Actualizado: dom., 2 de nov
Actualizado: dom., 2 de nov
Nombre
Proporción
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proporción0%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI